Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1747718

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1747718

Medication Adherence

PUBLISHED:
PAGES: 177 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Medication Adherence Market to Reach US$7.5 Billion by 2030

The global market for Medication Adherence estimated at US$3.4 Billion in the year 2024, is expected to reach US$7.5 Billion by 2030, growing at a CAGR of 13.9% over the analysis period 2024-2030. Hardware Centric Medication Adherence, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$5.5 Billion by the end of the analysis period. Growth in the Software Centric Medication Adherence segment is estimated at 10.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$900.8 Million While China is Forecast to Grow at 13.0% CAGR

The Medication Adherence market in the U.S. is estimated at US$900.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 13.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.0% and 11.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.0% CAGR.

Global Medication Adherence Market - Key Trends & Drivers Summarized

Why Is Medication Adherence Central to Patient Outcomes and Healthcare System Efficiency?

Medication adherence-the degree to which patients correctly follow prescribed medication regimens-is a critical determinant of treatment success, particularly for chronic conditions such as hypertension, diabetes, asthma, and cardiovascular disease. Non-adherence remains a widespread issue, leading to avoidable hospitalizations, disease progression, and increased healthcare costs. As healthcare systems shift toward value-based care and outcomes-based reimbursement, improving adherence is becoming both a clinical and economic imperative.

Patients may fail to adhere due to factors including forgetfulness, complex dosing schedules, cost barriers, side effects, or lack of understanding of the medication’s importance. Poor adherence affects not only individual health outcomes but also skews clinical trial data and reduces return on investment for pharmaceutical companies. Consequently, the demand for adherence-enhancing technologies, behavioral interventions, and smart packaging is gaining momentum across the healthcare ecosystem.

How Are Digital Tools and Behavioral Models Revolutionizing Adherence Strategies?

Digital health technologies are at the forefront of innovation in medication adherence. Smart pill bottles, mobile apps, ingestible sensors, and connected blister packs provide real-time reminders, usage tracking, and automated refill alerts. AI-powered adherence platforms analyze patient behavior patterns to deliver personalized nudges, risk stratification, and engagement through gamification or telehealth support. Integration with electronic health records (EHRs) enables providers to monitor adherence and intervene proactively when patterns indicate non-compliance.

Behavioral economics and patient-centric design are influencing the development of adherence solutions. Interventions now include motivational interviewing, pharmacist-led counseling, and reward systems that reinforce consistent medication use. Additionally, digital therapeutics (DTx) platforms are embedding adherence tracking into disease management programs-especially for mental health, oncology, and cardiometabolic conditions. These approaches are expanding the scope of adherence beyond reminders to include holistic support tailored to individual patient profiles.

Which Stakeholders and Therapies Are Driving Market Focus on Adherence?

Chronic disease management is the most adherence-sensitive segment, with payers, providers, and pharmaceutical companies all investing in solutions to close adherence gaps. Polypharmacy patients-especially the elderly and those with comorbidities-are key beneficiaries of multi-drug adherence platforms. Specialty therapies, such as biologics for rheumatoid arthritis or multiple sclerosis, face unique adherence challenges due to cost, injection fatigue, and delayed symptom relief, prompting tailored support systems.

Pharma companies are incorporating adherence technologies into companion apps and support programs to improve drug effectiveness and patient satisfaction. Insurers and pharmacy benefit managers (PBMs) are deploying adherence analytics to target high-risk populations and reduce hospital readmissions. Public health agencies are also involved, especially in infectious disease and preventive medicine campaigns, where adherence can significantly impact community health outcomes.

The Growth in the Medication Adherence Market Is Driven by Several Factors…

The growth in the medication adherence market is driven by the increasing global burden of chronic diseases, rising emphasis on value-based care, and rapid advancement in connected health technologies. A key driver is the proliferation of smart medication packaging and mobile-enabled reminder tools that promote real-time adherence tracking and reporting. The integration of adherence data with clinical decision support systems is enabling targeted interventions and improved care coordination.

Regulatory support for digital health solutions, increased payer interest in reducing avoidable treatment costs, and expanding use of personalized medicine are further amplifying demand. Growth is also supported by the pharmaceutical industry’s interest in improving real-world drug effectiveness and patient retention. As healthcare becomes more data-driven, adherence platforms will play a vital role in enhancing both therapeutic outcomes and operational efficiency across diverse health systems.

SCOPE OF STUDY:

The report analyzes the Medication Adherence market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Hardware Centric, Software Centric); Application (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

  • AdhereHealth
  • AdhereTech
  • AllazoHealth
  • Amazon Pharmacy (PillPack)
  • Cardinal Health
  • Cureatr
  • DrFirst
  • Everwell Health Solutions
  • Express Scripts
  • InhandPlus
  • Johnson & Johnson
  • Kinsa
  • McKesson Corporation
  • MedAdvisor International Pty Ltd
  • Medisafe
  • MedMinder Systems, Inc.
  • Omnicell, Inc.
  • PatientsLikeMe
  • Philips Healthcare
  • Wellth

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

Show more
Product Code: MCP35340

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Medication Adherence - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases Globally Drives Demand for Scalable Medication Adherence Solutions
    • Integration of Digital Health Tools and Mobile Apps Strengthens Patient Engagement in Daily Medication Management
    • Growth in Remote Patient Monitoring and Virtual Care Platforms Supports Real-Time Adherence Tracking Capabilities
    • OEM Development of Smart Pill Dispensers and Connected Inhalers Enhances Reminder and Dosing Accuracy
    • Payers and Providers Prioritize Value-Based Care Models That Tie Reimbursement to Medication Adherence Outcomes
    • Use of AI and Predictive Analytics Enables Early Detection of Non-Adherence and Tailored Intervention Strategies
    • Expansion of SMS, App-Based, and Voice-Activated Reminders Improves Access to Low-Cost Adherence Support Tools
    • Pharmacy-Led Adherence Programs and Medication Synchronization Services Increase Patient Refill Compliance
    • Increased Use of Unit-Dose and Pre-Packaged Medication Formats Simplifies Administration and Boosts Adherence in Seniors
    • Inclusion of Behavioral Nudges and Gamification Features Encourages Higher Participation in Digital Adherence Platforms
    • Integration of Medication Adherence Data Into EHRs and Care Management Tools Improves Clinical Decision Support
    • Growth in At-Home Infusion and Specialty Drug Delivery Fuels Need for Adherence Monitoring in Complex Regimens
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Medication Adherence Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Medication Adherence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Medication Adherence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Medication Adherence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hardware Centric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hardware Centric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Hardware Centric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Software Centric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Software Centric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Software Centric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Central Nervous System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Central Nervous System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Central Nervous System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Gastrointestinal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Musculoskeletal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Musculoskeletal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Musculoskeletal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Medication Adherence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Medication Adherence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Medication Adherence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Medication Adherence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Medication Adherence by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Medication Adherence by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Medication Adherence by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Medication Adherence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Medication Adherence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Medication Adherence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Medication Adherence Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Medication Adherence by Type - Hardware Centric and Software Centric - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Medication Adherence by Type - Hardware Centric and Software Centric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of World 15-Year Perspective for Medication Adherence by Type - Percentage Breakdown of Value Sales for Hardware Centric and Software Centric for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Medication Adherence by Application - Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of World 15-Year Perspective for Medication Adherence by Application - Percentage Breakdown of Value Sales for Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!